There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial ...
ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.
Patients who received neoadjuvant systemic therapy followed by surgical resection for mucosal HNSCC in the US National Cancer Database (2004-2022) were evaluated using 1:5 propensity score matching to ...
Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.